POCARD

POCARD is a Russian medical device company focused on therapeutic apheresis and extracorporeal blood purification technologies. Founded in 1992, the company develops and manufactures adsorption columns used to selectively remove pathogenic molecules, lipoproteins, endotoxins, antibodies, and immune complexes from blood or plasma. Its commercial product portfolio includes Toxipak, Lipopak, Immuno-Adsopak, ImmunoCore, and ABO Adsopak, which are positioned across sepsis, lipid disorders, autoimmune conditions, and transplantation-related applications. POCARD appears to operate an integrated model spanning target discovery, sorbent development, aseptic manufacturing, and commercialization. The company positions itself as a specialist platform player in adsorption technologies for therapeutic apheresis rather than a traditional drug developer.